RAD51

RAD51製品

All (7)
RAD51阻害剤 (5)
RAD51活性剤(1)
新製品

製品コード	製品名称	製品説明	文献中Selleckの製品使用例
S2871	T0070907	T0070907 is a potent inhibitor of PPARγ (peroxisome proliferator activator receptor γ ) that induces G2/M arrest and enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. It also acts as an antagonist of PPARγ that suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.	Cell Rep Med, 2025, 6(10):102373 Front Pharmacol, 2025, 16:1559446 Sci Rep, 2025, 15(1):17232
S1244	Amuvatinib (MP-470)	Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.	Cancer Res, 2025, 10.1158/0008-5472.CAN-24-2220 Hematol Oncol, 2025, 43(5):e70131 bioRxiv, 2024, 2023.11.21.568071
S8077	RI-1	RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.	Cell Rep Med, 2025, 6(8):102284 MedComm (2020), 2024, 5(8):e690 Cell Death Discov, 2024, 10(1):434
S8234	RS-1	RS-1 is a RAD51-stimulatory compound, which increases the DNA binding activity of RAD51. It is an HDR(homology-directed repair) enhancer.	Sci Bull (Beijing), 2025, S2095-9273(25)00865-5 Funct Integr Genomics, 2025, 25(1):180 J Biomed Sci, 2024, 31(1):68
F1110	Rad51 Antibody [H22D22]	Rad51 Rabbit mAb recognizes endogenous levels of total Rad51 protein.
E0308^New	RAD51-IN-17	RAD51 - IN - 1はB02の誘導体であり、RAD51の強力な阻害剤です。RAD51 - IN - 1はがん研究に使用できます。
S9941^New	Emzadirib	Emzadirib an inhibitor of RAD51 exhibits a reduction in RAD51 foci. Emzadirib displays significant anti-tumor activity with tumor growth inhibition in in vivo and in vitro models.
S2871	T0070907	T0070907 is a potent inhibitor of PPARγ (peroxisome proliferator activator receptor γ ) that induces G2/M arrest and enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. It also acts as an antagonist of PPARγ that suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.	Cell Rep Med, 2025, 6(10):102373 Front Pharmacol, 2025, 16:1559446 Sci Rep, 2025, 15(1):17232
S1244	Amuvatinib (MP-470)	Amuvatinib (MP-470, HPK 56) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Amuvatinib suppresses c-MET and c-RET. Amuvatinib is also active as a DNA repair protein Rad51 inhibitor with antineoplastic activity. Phase 2.	Cancer Res, 2025, 10.1158/0008-5472.CAN-24-2220 Hematol Oncol, 2025, 43(5):e70131 bioRxiv, 2024, 2023.11.21.568071
S8077	RI-1	RI-1 (RAD51 inhibitor 1) is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.	Cell Rep Med, 2025, 6(8):102284 MedComm (2020), 2024, 5(8):e690 Cell Death Discov, 2024, 10(1):434
E0308^New	RAD51-IN-17	RAD51 - IN - 1はB02の誘導体であり、RAD51の強力な阻害剤です。RAD51 - IN - 1はがん研究に使用できます。
S9941^New	Emzadirib	Emzadirib an inhibitor of RAD51 exhibits a reduction in RAD51 foci. Emzadirib displays significant anti-tumor activity with tumor growth inhibition in in vivo and in vitro models.
S8234	RS-1	RS-1 is a RAD51-stimulatory compound, which increases the DNA binding activity of RAD51. It is an HDR(homology-directed repair) enhancer.	Sci Bull (Beijing), 2025, S2095-9273(25)00865-5 Funct Integr Genomics, 2025, 25(1):180 J Biomed Sci, 2024, 31(1):68
E0308^New	RAD51-IN-17	RAD51 - IN - 1はB02の誘導体であり、RAD51の強力な阻害剤です。RAD51 - IN - 1はがん研究に使用できます。
S9941^New	Emzadirib	Emzadirib an inhibitor of RAD51 exhibits a reduction in RAD51 foci. Emzadirib displays significant anti-tumor activity with tumor growth inhibition in in vivo and in vitro models.